The programme offers students a comprehensive 36-week internship during their final year, providing in-depth exposure to leading biopharmaceutical companies. Republic Polytechnic (RP) has partnered ...

British drug maker GSK on Monday said it will buy US biopharmaceutical company IDRx for up to $1.15 billion. The Boston-based biotechnology firm is developing therapeutics for the treatment of ...

With its stock down 18% over the past three months, it is easy to disregard NeuroScientific Biopharmaceuticals (ASX:NSB). We, however decided to study the company's financials to determine if they ...

For that reason, in this series, we're not playing this guessing game. Day One Biopharmaceuticals Inc (NASDAQ:DAWN) is a commercial-stage biopharmaceutical company based in Brisbane, California ...

Gujarat-based drugmaker Intas Pharmaceuticals Ltd., which counts private equity firm ChrysCapital, Singapore state investment firm Temasek and Abu Dhabi Investment Authority (ADIA) as its investors, ...

SAN FRANCISCO, Jan 14 (Reuters) - The biopharmaceutical industry is aiming for a 2025 reversal of last year's slump in investor returns but remains wary over what President-elect Donald Trump's ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

2024 was a difficult year for the pharmaceutical industry; do brighter times lie ahead? Source: Cygnus. Times are tough in the biopharmaceutical industry. Challenges including regulatory hurdles, ...